Short Interest in ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Grows By 38.7%

ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Get Rating) saw a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 19,700 shares, an increase of 38.7% from the March 31st total of 14,200 shares. Based on an average daily volume of 22,200 shares, the short-interest ratio is presently 0.9 days.

Shares of NASDAQ BIS opened at $28.99 on Friday. ProShares UltraShort Nasdaq Biotechnology has a 1-year low of $15.86 and a 1-year high of $30.00. The business’s 50 day moving average is $25.56 and its 200-day moving average is $23.01.

A number of institutional investors have recently bought and sold shares of BIS. IMC Chicago LLC increased its stake in ProShares UltraShort Nasdaq Biotechnology by 93.3% during the 3rd quarter. IMC Chicago LLC now owns 27,459 shares of the company’s stock worth $495,000 after acquiring an additional 13,256 shares during the period. UBS Group AG increased its stake in ProShares UltraShort Nasdaq Biotechnology by 113.2% during the 3rd quarter. UBS Group AG now owns 3,026 shares of the company’s stock worth $55,000 after acquiring an additional 1,607 shares during the period. Finally, OLD Mission Capital LLC bought a new position in ProShares UltraShort Nasdaq Biotechnology during the 4th quarter worth $266,000.

ProShares UltraShort Nasdaq Biotechnology Company Profile (Get Rating)

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.

Further Reading